GERN vs HBAN · rev $109.3M vs P/E 13, rev $1.56B
Geron Corporation (GERN) versus Huntington Bancshares Incorporated (HBAN) — a side-by-side from cached financials, not a winner call.
Geron Corporation (GERN) is a biotechnology company listed on US.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Latest reported GERN revenue for 2026-06-30 was $109.3M. Net income was -$20.3M. GERN currently screens at market cap $878.9M.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
GERN currently screens at market cap $878.9M. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Not investment advice. Open the GERN and HBAN stock pages for the full models.
Not investment advice.